• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives

Recent Advances in the Application of 3-(Difluoromethoxy)benzoyl Chloride (CAS: 76903-91-8) in Chemical and Pharmaceutical Research

3-(Difluoromethoxy)benzoyl chloride (CAS: 76903-91-8) has emerged as a key synthetic intermediate in pharmaceutical and agrochemical research due to its unique structural features. Recent studies have highlighted its versatility in constructing biologically active molecules, particularly in the development of novel anti-inflammatory and antimicrobial agents. The difluoromethoxy group's electron-withdrawing properties and metabolic stability make this compound particularly valuable for medicinal chemistry applications.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's utility in synthesizing potent COX-2 inhibitors. Researchers utilized 3-(difluoromethoxy)benzoyl chloride as a key building block to create a series of diarylheterocycle derivatives showing remarkable selectivity for COX-2 over COX-1 (IC50 ratio > 300). The presence of the difluoromethoxy moiety was found to significantly enhance metabolic stability compared to traditional methoxy-substituted analogs.

In the field of agrochemicals, recent patent applications (WO2023052141, 2023) have disclosed novel insecticidal compounds incorporating 3-(difluoromethoxy)benzoyl chloride derivatives. These compounds exhibit improved photostability and systemic activity against resistant insect populations. The fluorinated structure appears to reduce oxidative degradation while maintaining excellent translocation properties in plant tissues.

Significant progress has been made in the synthetic methodology for 3-(difluoromethoxy)benzoyl chloride. A 2024 publication in Organic Process Research & Development described an improved continuous-flow synthesis route that achieves 92% yield with excellent purity (>99.5%). This advancement addresses previous challenges in large-scale production, particularly regarding the control of exothermic reactions during the chlorination step.

The compound's application in PET radiopharmaceuticals has shown particular promise. Recent preclinical studies have demonstrated that 18F-labeled analogs derived from 3-(difluoromethoxy)benzoyl chloride scaffolds exhibit excellent blood-brain barrier penetration and target specificity for neurological disorders. This development opens new avenues for diagnostic imaging of neurodegenerative diseases.

Emerging research suggests potential applications in antiviral drug discovery. Molecular docking studies indicate that derivatives of 3-(difluoromethoxy)benzoyl chloride may interact with conserved regions of viral proteases. Current investigations are focusing on structure-activity relationships to optimize binding affinity while maintaining favorable pharmacokinetic profiles.

The safety profile of 3-(difluoromethoxy)benzoyl chloride has been extensively characterized in recent toxicological assessments. While the compound requires careful handling due to its acyl chloride reactivity, studies confirm that proper containment measures effectively mitigate occupational hazards. The environmental fate of degradation products has also been investigated, with findings supporting relatively rapid hydrolysis under typical wastewater treatment conditions.

Future research directions appear to be focusing on expanding the structural diversity accessible from this versatile intermediate. Particularly promising areas include the development of chiral derivatives for asymmetric synthesis and the creation of bifunctional linkers for targeted drug delivery systems. The continued evolution of synthetic methodologies is expected to further enhance the accessibility and application scope of this valuable chemical building block.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)